Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...

By 2013 it was working on an oral IL-23 receptor antagonist ... Novartis’s top-selling IL-17 antagonist antibody secukinumab (Cosentyx) is on track to earn nearly $6.8 billion in 2025, and ...